Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-001688-31Phase 2Active
Phase 2, open-label trial of zolpidem in Insomnia (2 arms), sponsored by Larimar Therapeutics. Primary endpoints: Night 63-lead EEG recording and Night polysomnographic recording. Started Apr 2007; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-001688-31.